GlassScriptPhysician profile
Timothy Mccullough
NPI 1457727893
$2,209.81
in general payments reported to CMS, 2019-2025
26 companies · $267 in 2025
The $267 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $409 · 2022: $506 · 2023: $382 · 2024: $646 · 2025: $267.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,296.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,295.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $469.75 | 2021-2025 | Lifevest |
| Nuwellis, INC. | $194.19 | 2021-2024 | Aquadex Smartflow Console |
| Abbott Laboratories | $161.41 | 2021-2024 | Thoratec Heartmate 3 Lvas Implant Kit |
| Lexicon Pharmaceuticals, INC. | $121.83 | 2024 | Inpefa |
| Atricure, INC. | $117.46 | 2022-2024 | |
| Abiomed | $116.25 | 2021-2022 | |
| Music City Medical Technologies, LLC | $111.71 | 2024-2025 | |
| Ethicon US, LLC | $103.51 | 2023 | Vistaseal, Prolene, Ethicon |
| Stryker Corporation | $103.30 | 2021-2024 | Na, Stryker Varispeed |
| Pfizer INC. | $91.08 | 2021-2025 | |
| La Jolla Pharmaceutical Company | $90.71 | 2023-2025 | Giapreza |
| Cerus Corporation | $72.50 | 2023-2024 | Intercept Blood System For Platelets |
| Janssen Pharmaceuticals, INC | $68.06 | 2021-2022 | |
| Bolton Medical INC | $63.26 | 2023-2024 | Treo Abdominal Stent-Graft System |
| Baxter Healthcare | $43.86 | 2025 | Perclot |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $43.19 | 2022 | |
| Octapharma USA, INC. | $34.22 | 2025 | Fibryga |
| Chiesi USA, INC. | $33.91 | 2023-2024 | Kengreal, Cleviprex |
| Kci USA, INC. | $31.52 | 2022-2023 | Prevena |
| Angiodynamics, INC. | $27.18 | 2022 | |
| Amgen INC. | $24.62 | 2022 | |
| Potrero Medical, INC. | $23.65 | 2023 | |
| Haemonetics Corporation | $19.37 | 2022 | |
| Werfen USA LLC | $15.77 | 2021 | |
| Alpha Orthopedic Systems | $14.34 | 2023 | |
| Corcym INC | $13.16 | 2024 | Perceval |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Mccullough listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.